Brown, D. A. | Search bioRxiv

bioRxiv2026

EEG Oscillations in Guided Mindfulness versus Mind-Wandering in Young Adults: Effects of Auditory Task Instruction and Naturalistic Video

Alpha and theta band EEG oscillations have been implicated in states of mindfulness meditation. However, results are inconsistent and the influence of testing environment variables is not well-characterized. We used EEG to measure the amplitude of brain oscillations in a mindful-attention versus mind-wandering condition, in which guided auditory instructions were interleaved with periods of silence, with and without accompanying naturalistic video projections. We generated precise measures of alpha and theta in a sample of 20 young-adult non-expert meditators, by identifying each participant's individual alpha peak frequency (IAF) from posterior EEG electrodes and using it to define four individualized frequency bands: two low alpha bands (in 2 Hz increments below the IAF), one upper alpha band (from IAF to 2 Hz above IAF), and one theta band (4 Hz - 6 Hz below IAF). We found that the mindfulness manipulation significantly increased power in alpha ranging between 2 Hz below to 2 Hz above IAF, including peak alpha amplitude, compared with mind-wandering. Meanwhile, central theta amplitude was larger when auditory instructions were on versus off, and naturalistic video did not reliably modulate the EEG effects of mindfulness. We conclude that the acute effects of mindfulness in non-expert meditators are most consistently observed as increases of posterior alpha-band activity, and that auditory task-instructions should be accounted for in studies of guided meditation. Observed alpha increases may reflect induced states of calm or relaxation induced by mindfulness practice, as proposed in previous studies. These results may apply to mindfulness training or biofeedback therapies.

neuroscience↗

bioRxiv2018

Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis

Genome wide association studies have identified >200 susceptibility loci accounting for much of the heritability of Multiple Sclerosis (MS). Epstein Barr virus (EBV), a memory B cell tropic virus, has been identified as necessary but not sufficient for development of MS, with evidence for disease causation. The molecular and immunological basis for this has not been established. LCL proliferation is driven by signalling through the EBV produced cell surface protein LMP1, a homologue of the MS risk gene CD40. We show that the CD40 ligand, CD40L, potentially through competitive signalling with LMP1, reduces LCL proliferation (p<0.001). The MS risk variants of the LMP1 signalling inhibitor, TRAF3, had altered expression in B cells and LCLs. Both CD40 and TRAF3 risk SNPs are in binding sites for the EBV transcription factor EBNA2. We have investigated transcriptomes of B cells and EBV infected B cells at Latency III (LCLs) and identified 47 MS risk genes with altered expression, associated with the risk genotype. Overall these MS risk SNPs were overrepresented in target loci of the EBV transcription factor EBNA2 (p<10-16), in genes dysregulated between B and LCLs (p<10-5), and as targets for EBV miRNAs (p<10-4). The risk gene ZC3HAV1 is the putative target for multiple EBV miRNAs. It amplifies the interferon response, and was shown to have reduced expression in LCLs for the risk allele. These data indicate targeting EBV EBNA2, miRNAs, and MS risk genes on the LMP1/LMP2 pathways, and the pathways themselves, may be of therapeutic benefit in MS.

genomics↗